Mice Model Market size to exceed $11.7bn by 2025

Mice Model Market size is set to exceed USD 11.7 billion by 2025; according to a new research report by Global Market Insights, Inc.

Growing adoption of mice in fundamental research, pathological, physiological, and research studies will enhance the mice model industry growth over the upcoming years. The rapid market growth is owing to rise in preclinical drug evaluation that has augmented the demand for mice model. Hence, the aforementioned factors will play a substantial role in enhancing the market growth in the forthcoming years.


Request Sample Buy NowInquiry Before Buying


Rise in number of animal testing procedures on mice model for certifying drug safety will boost the industry demand

Growing preference of mice in research and development activities of pharma and biotech industries is expected to boost the market demand in the upcoming years. The demand for mice model is significantly growing in the U.S. in order to understand the mechanism of Alzheimer’s and cancer cases. For instance, according to the World Health Organization, in 2018, around 18.1 million new cancer cases were reported and around 9.6 million deaths occurred due to cancer across the globe. Upsurge in use of mice in identifying autoimmune diseases will boost the market growth positively. Mice are further used to study the efficacy and safety of the drugs before testing in the clinical trials. However, factors that are impeding the market growth are strict regulations, guidelines and opposition on testing on mice models by several organization across worldwide.

Browse key industry insights spread across 450 pages with 376 market data tables & 11 figures & charts from the report, “Mice Model Market Size By Mice Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Switzerland, Netherlands, Czech Republic, Poland, Belgium, Finland, Hungary, Denmark, Ireland, Sweden, China, Japan, Australia, South Korea, New Zealand, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Israel), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents:

Regular use of animal testing on knockout models will enhance the industry growth

Based on the type of animal, the market is segmented as inbred, outbred, knockout, hybrid and others. Knockout mice model market is estimated to witness fastest growth at around 9% over the forecast period. These models are currently in high demand owing to several attributes that it provides. Knockout models mimic Alzheimer’s diseases and assist in understanding the disease indication mechanisms and offer valuable tools for assessing potential therapeutic strategies. Furthermore, these knockout models assist in various areas of biomedical research including cardiovascular & neurological disorders, diabetes, and autoimmune disorders. Hence, the above-mentioned factors will play vital role in enhancing the industry growth in the future.

Embryonic stem cell injection technology is expected to pave attractive growth opportunities for researchers in genetically modifying animals

Based on technology, the market is segmented as CRISPR, embryonic stem cell injection, microinjection, nuclear transfer and others. Embryonic stem cell injection in mice testing is projected to witness around 8% growth over the forecast period. The high growth rate is owing to several advantages the mice model offers over other animal models such as behavioral, transplantation and pharmacokinetic studies. These genetically modified mice are used in biomedical research that help in detecting number of diseases that harm humans. Hence, aforementioned factors are expected to propel the market share in the upcoming years.

Increasing statistics of anatomical and physiological similarities between mice and humans will boost the market demand

On the basis of application of mice models, the market is segmented as research and development, academics, production and quality control and, others. Application of mice in academic studies was valued at around USD 132 million in the year 2018. Growing usage of laboratory mice for academic studies will propel the mice model market. The upsurge of mice for biomedical research has further uplifted the market demand. The growth is attributed to several physiological, anatomical, and genetic similarities between mice and humans that they share. Thus, these similarities have resulted in inspiring the researchers to study basic and fundamental biological research studies in mice before applying them on humans. Hence, growing number of mice for studying behavioral and function science is expected to boost the segmental growth.

Veterinary research is set to proceed promptly due to ongoing treatment for animals with the help of mice model which will further spur the market size

The use segment is segregated as veterinary and human. The use of mice in veterinary research is projected to expand at around 7.5% CAGR over the forecast period. The growth is attributed to the fact that animal research testing has prevented the lives of millions of companion animals. For instance, tetanus and rabies vaccine to prevent distemper, infectious hepatitis, parvovirus among others are some of the diseases for which research has been conducted on mice. Hence, all these factors are expected to gain a significant traction that will further impel the segmental growth in the upcoming years.

Contract research organizations will emerge as the centerpiece for the growth of global market

Based on end-use segment, the mice model market is segmented as companies, academic and research institutes, organizations, and contract research organizations (CROs). The adoption of mice in the contract research organizations (CROs) was estimated at around USD 517 million in the year 2018. Growing demand and adoption rate of mice by the contract research organizations for research and development activities will augment the industry growth in the near future. Several researches are conducted on mice in CROs in order to procure knowledge regarding numerous diseases such as neurological disorders, immunological disfunction, transplantation, aging, carcinogenesis, among others. Hence, the above-mentioned factors are contributing to the adoption of mice thereby, propelling the market growth.

UK dominated the Europe mice model market with more than 30% market share owing to growing use of mice models in research activities

UK dominated the Europe mice model market with around 30% of European market in the year 2018. Growing demand for mice models in the country owing to increase in research and development regarding the biological and physiological behavior of diseases will enhance the market size in the country. Mice model in UK has been used to research several diseases such as Alzheimer’s, diabetes, cancer and cardiovascular diseases. Hence, growing research and development activities will supplement the adoption rate of mice models thereby, fueling the market growth in the near future.

Increase in strategic initiatives such as acquisitions, mergers, partnerships and collaborations by major industry players will enhance the mice model market growth in future

Prominent market players in the mice model industry include Envigo, genOway, Charles River, Transviragen Inc., Janvier Labs, Taconic Biosciences Inc. and Transpogen Biopharmaceutical, Inc. The key players focus on several major strategies such as partnerships & collaborations, acquisition, merger, new product development and launch in order to expand their product portfolio and geographical expansion. For instance, in August 2018, Charles River Laboratories completed the acquisition of MPI Research. The acquisition benefitted the company in providing comprehensive drug testing services. It also led to important expansion of the treatment option, high-quality services, and complementary capabilities thereby resulting in better client support and biotechnology client base expansion.

Explore More on Related Topics:


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X